Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04045028
Title A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD), and Preliminary Activity of Tiragolumab in Participants With Relapsed or Refractory Multiple Myeloma or With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Genentech, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Colorado Blood Cancer Institute (CBCI) at Presbyterian/ St. Luke's Medical Center Denver Colorado 80218 United States Details
Emory Clinic Atlanta Georgia 30322 United States Details
University of Maryland Baltimore Maryland 21201 United States Details
Washington University Saint Louis Missouri 63128 United States Details
Clinical Research Alliance Westbury New York 11590 United States Details
Oncology Hematology Care, Inc. Cincinnati Ohio 45236 United States Details
University of Pennsylvania; School of Medicine Philadelphia Pennsylvania 19104 United States Details
SCRI Nashville Tennessee 37203 United States Details
Virginia Cancer Specialists (Fairfax) - USOR Fairfax Virginia 22031 United States Details
Samsung Medical Center; Nephrology Department Seoul 06351 Korea, Republic of Details
Seoul National University Hospital Seoul 110-744 Korea, Republic of Details
Yonsei Cancer Center; Yonsei Uni Coll. Med. Seoul 120-752 Korea, Republic of Details
Seoul St.Mary's Hospital; Medical Oncology Seoul 137-807 Korea, Republic of Details
Asan Medical Center; Internal Dept / Gastorenterology Seoul 138-736 Korea, Republic of Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field